{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:33:45Z","timestamp":1793205225847,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1053\/j.ajkd.2005.03.016","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T09:08:52Z","timestamp":1134464932000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Enzyme Replacement Therapy in Fabry Disease Patients Undergoing Dialysis: Effects on Quality of Life and Organ Involvement"],"prefix":"10.1053","volume":"46","author":[{"given":"Antonio","family":"Pisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Andreucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deni","family":"Procaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Abbaterusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Savoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Comotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cianciaruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2005.03.016_bib1","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","article-title":"Clinical feature of and recent advances in therapy for Fabry disease","volume":"284","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2005.03.016_bib2","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease, in Schriver et al (eds): The Metabolic and Molecular Bases of Inherited Disease","author":"Desnick","year":"2001"},{"key":"10.1053\/j.ajkd.2005.03.016_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1053\/j.ajkd.2005.03.016_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2005.03.016_bib5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.ajkd.2005.03.016_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000059897","article-title":"Kidney involvement in Anderson-Fabry disease","volume":"122","author":"Meroni","year":"1997","journal-title":"Contrib Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","article-title":"Patients with Fabry disease on dialysis in the United States","volume":"61","author":"Thadhani","year":"2002","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.016_bib8","first-page":"S113","article-title":"Screening for Fabry disease in end-stage nephropathies","volume":"25","author":"Spada","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.ajkd.2005.03.016_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.016_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a nationwide screening for Anderson-Fabry disease among dialysis patients","volume":"15","author":"Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.03.016_bib12","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2005.03.016_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"The Committee on M-Mode Standardization of the American Society of Ecocardiography. Recommendations regarding M-mode echocardiography: Results of a survey of echocardiographic measurements","volume":"58","author":"Shan","year":"1978","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.016_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.016_bib15","first-page":"S1280","article-title":"Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass","volume":"84","author":"Schiller","year":"1991","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.016_bib16","first-page":"S107","article-title":"US Renal Data System","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.016_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.016_bib18","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V1251079","article-title":"Left ventricular hypertrophy in renal patients","volume":"12","author":"Middleton","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib19","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic feature and their serial change in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.016_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","article-title":"Prognostic significance of serial changes in left ventricular mass in essential hypertension","volume":"97","author":"Verdecchia","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.016_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.016_bib22","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis","volume":"12","author":"London","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib23","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.V12122768","article-title":"Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis","volume":"12","author":"Zoccali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"issue":"suppl","key":"10.1053\/j.ajkd.2005.03.016_bib25","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1097\/01.ASN.0000015238.98011.AF","article-title":"Cardiac involvement in Anderson Fabry disease","volume":"13","author":"Kampmann","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.016_bib26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease","volume":"108","author":"Waidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.016_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/hrt.2003.023903","article-title":"Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A","volume":"90","author":"Komamura","year":"2004","journal-title":"Heart"},{"key":"10.1053\/j.ajkd.2005.03.016_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with algasidase beta improves cardiac involvement in Fabry\u2019s disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Gen"},{"key":"10.1053\/j.ajkd.2005.03.016_bib29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605004531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605004531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:31:07Z","timestamp":1759455067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638605004531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0272638605004531"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.03.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme Replacement Therapy in Fabry Disease Patients Undergoing Dialysis: Effects on Quality of Life and Organ Involvement","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}